These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25474857)

  • 1. Oral mucosal immunotherapy using a toothpaste delivery system for the treatment of allergic rhinitis.
    Reisacher W; Rudner S; Kotik V
    Int J Pharm Compd; 2014; 18(4):287-90. PubMed ID: 25474857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of quantifying skin reactivity in treating allergic rhinitis with immunotherapy.
    Trevino RJ; Veling MC
    Ear Nose Throat J; 2000 May; 79(5):362-4, 366. PubMed ID: 10832201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells as potential targets for mucosal immunotherapy.
    Allam JP; Bieber T; Novak N
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):554-7. PubMed ID: 19745726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral allergy syndrome successfully treated with pollen immunotherapy.
    Kelso JM; Jones RT; Tellez R; Yunginger JW
    Ann Allergy Asthma Immunol; 1995 May; 74(5):391-6. PubMed ID: 7749969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy and influence on urinary leukotrienes in seasonal pediatric allergy.
    Yuksel H; Tanac R; Gousseinov A; Demir E
    J Investig Allergol Clin Immunol; 1999; 9(5):305-13. PubMed ID: 10582199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy for allergic rhinitis.
    Med Lett Drugs Ther; 2014 Jun; 56(1444):47-8. PubMed ID: 24933088
    [No Abstract]   [Full Text] [Related]  

  • 9. Nasal immunotherapy in weed-induced allergic rhinitis.
    Gaglani B; Borish L; Bartelson BL; Buchmeier A; Keller L; Nelson HS
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):259-65. PubMed ID: 9305235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral allergy syndrome in patients with airborne pollen allergy treated with specific immunotherapy.
    Czarnecka-Operacz M; Jenerowicz D; Silny W
    Acta Dermatovenerol Croat; 2008; 16(1):19-24. PubMed ID: 18358104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual immunotherapy: where do we stand? Present and future.
    Passalacqua G; Pawankar R; Baena-Cagnani CE; Canonica GW
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):1-3. PubMed ID: 19106697
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic rhinitis.
    Kemp AS
    Paediatr Respir Rev; 2009 Jun; 10(2):63-8. PubMed ID: 19410204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
    Bertoni M; Cosmi F; Bianchi I; Di Berardino L
    Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New allergy intervention strategies: hitting the mucosal road.
    Wiedermann U; Mercenier A
    Clin Exp Allergy; 2007 Apr; 37(4):473-5. PubMed ID: 17430341
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide.
    Wüthrich B; Gumowski PL; Fäh J; Hürlimann A; Deluze C; André C; Fadel R; Carat F
    J Investig Allergol Clin Immunol; 2001; 11(3):149-56. PubMed ID: 11831445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe.
    Cox L; Calderon MA
    Curr Med Res Opin; 2010 Dec; 26(12):2723-33. PubMed ID: 20979432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy.
    Kopp MV; Hamelmann E; Bendiks M; Zielen S; Kamin W; Bergmann KC; Klein C; Wahn U;
    Pediatr Allergy Immunol; 2013 Aug; 24(5):427-33. PubMed ID: 23799935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific immunotherapy against allergic rhinitis: the state of the art.
    Fujimura T; Okamoto Y
    Allergol Int; 2010 Mar; 59(1):21-31. PubMed ID: 20093851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: a double-blind study.
    Troise C; Voltolini S; Canessa A; Pecora S; Negrini AC
    J Investig Allergol Clin Immunol; 1995; 5(1):25-30. PubMed ID: 7551201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.